BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2537 related articles for article (PubMed ID: 19721448)

  • 1. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
    Shalitin S; Abrahami M; Lilos P; Phillip M
    Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma adiponectin levels in overweight and obese Asians.
    Yang WS; Lee WJ; Funahashi T; Tanaka S; Matsuzawa Y; Chao CL; Chen CL; Tai TY; Chuang LM
    Obes Res; 2002 Nov; 10(11):1104-10. PubMed ID: 12429873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
    Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
    Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting-based estimates of insulin sensitivity in overweight and obesity: a critical appraisal.
    Ruige JB; Mertens IL; Bartholomeeusen E; Dirinck E; Ferrannini E; Van Gaal LF
    Obesity (Silver Spring); 2006 Jul; 14(7):1250-6. PubMed ID: 16899806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
    Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
    Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of different metabolic syndrome classifications on the metabolic syndrome prevalence in a young Middle Eastern population.
    Chedid R; Gannagé-Yared MH; Khalifé S; Halaby G; Zoghbi F
    Metabolism; 2009 Jun; 58(6):746-52. PubMed ID: 19446111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome and insulin resistance significantly correlate with body mass index.
    Esteghamati A; Khalilzadeh O; Anvari M; Ahadi MS; Abbasi M; Rashidi A
    Arch Med Res; 2008 Nov; 39(8):803-8. PubMed ID: 18996295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans.
    Rhee EJ; Kim YC; Lee WY; Jung CH; Sung KC; Ryu SH; Oh KW; Kim SW
    Metabolism; 2006 Feb; 55(2):183-7. PubMed ID: 16423624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients.
    Taniguchi A; Fukushima M; Sakai M; Kataoka K; Nagata I; Doi K; Arakawa H; Nagasaka S; Tokuyama K; Nakai Y
    Metabolism; 2000 Aug; 49(8):1001-5. PubMed ID: 10954017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance.
    Meshkani R; Taghikhani M; Larijani B; Khatami S; Khoshbin E; Adeli K
    Clin Chim Acta; 2006 Sep; 371(1-2):169-75. PubMed ID: 16714005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic syndrome in overweight and obese schoolchildren in Beijing].
    Wan NJ; Mi J; Wang TY; Duan JL; Li M; Gong CX; Du JB; Zhao XY; Cheng H; Hou DQ; Wang L
    Zhonghua Er Ke Za Zhi; 2007 Jun; 45(6):417-21. PubMed ID: 17880785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
    Cambuli VM; Incani M; Pilia S; Congiu T; Cavallo MG; Cossu E; Sentinelli F; Mariotti S; Loche S; Baroni MG
    Diabetes Metab Res Rev; 2009 Sep; 25(6):528-34. PubMed ID: 19496065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.
    Vogeser M; König D; Frey I; Predel HG; Parhofer KG; Berg A
    Clin Biochem; 2007 Sep; 40(13-14):964-8. PubMed ID: 17583689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
    Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
    Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional fat mass by DXA: high leg fat mass attenuates the relative risk of insulin resistance and dyslipidaemia in obese but not in overweight postmenopausal women.
    Aasen G; Fagertun H; Halse J
    Scand J Clin Lab Invest; 2008; 68(3):204-11. PubMed ID: 18446527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between several insulin sensitivity indices and metabolic risk factors in overweight and obese postmenopausal women: a MONET study.
    Malita FM; Messier V; Lavoie JM; Bastard JP; Rabasa-Lhoret R; Karelis AD
    Nutr Metab Cardiovasc Dis; 2010 Mar; 20(3):173-9. PubMed ID: 19501492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 127.